Skip to main content

Table 5 Expected and observed incidence rates of MDS/AML by age per 100000 person years.

From: Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005

Leukemia

Type

Age

Expected

Rate*

Person

years

Observed

Rate

Expected

Cases

Observed

Cases

Rate Ratio

(95% CI)

MDS

< 65

1.6

28538

17.5

0.46

5

10.88

(3.84, 24.03)

 

≥ 65

31.6

12027

41.6

3.80

5

1.31

(0.47, 2.84)

 

All

6.7

40565

24.7

2.71

10

3.70

(1.85, 6.54)

AML

< 65

2.0

28538

10.5

0.57

3

5.32

(1.31, 14.04)

 

≥ 65

14.0

12027

33.3

1.68

4

2.38

(0.73, 5.61)

 

All

4.0

40565

17.3

1.62

7

4.32

(1.85, 8.45)

MDS/AML

< 65

3.6

28538

28.1

1.03

8

7.82

(3.54, 14.77)

 

≥ 65

45.6

12027

74.8

5.48

9

1.64

(0.79, 2.98)

 

All

10.6

40565

41.9

4.30

17

3.94

(2.34, 6.15)

  1. *SEER 9 incidence rates, Seattle-Puget Sound Region [24]